calendar
7,990 catalysts · 3,350 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k
next 91 dayslessmore
MonWedFri
7,990 catalysts · 3,350 8k filing · 1,368 grant · 1,000 device adverse event · 615 approval · 582 earnings · 476 device 510k
Product code: LPL. Advisory committee: Ophthalmic. Type: Traditional
Product code: ILY. Advisory committee: Physical Medicine. Type: Traditional
Product code: KGN. Advisory committee: Unknown. Type: Special
Product code: DQX. Advisory committee: Cardiovascular. Type: Special
Supplement type: Normal 180 Day Track. Product code: PLS. Advisory committee: PA. Decision: APPR
Supplement type: 30-Day Notice. Product code: NEK. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: OZP. Advisory committee: CH. Decision: OK30
Supplement type: 30-Day Notice. Product code: NPZ. Advisory committee: DE. Decision: OK30
Supplement type: Normal 180 Day Track No User Fee. Product code: QCD. Advisory committee: CH. Decision: APPR
Supplement type: 30-Day Notice. Product code: SFI. Advisory committee: CH. Decision: OK30
Supplement type: 30-Day Notice. Product code: NGV. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: ONU. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MPW. Advisory committee: OR. Decision: OK30
Supplement type: Special (Immediate Track). Product code: MER. Advisory committee: GU. Decision: APPR
CA grant. $385,333. PI: Edward Bo-yi Chuong
CA grant. $437,654. PI: Jason A. Hanna
CA grant. $403,686. PI: Christopher J. Halbrook
HL grant. $74,631. PI: Hunter B Moore
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: MAP77. Form: SOLUTION. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: QUAGEN. Form: SOLUTION. Route: ORAL
Product code: KPE. Advisory committee: General Hospital. Type: Traditional
Product code: OBP. Advisory committee: Neurology. Type: Traditional
Product code: EMA. Advisory committee: Dental. Type: Traditional
Product code: GGW. Advisory committee: Hematology. Type: Special
Product code: HEB. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: OZT. Advisory committee: Cardiovascular. Type: Special
Product code: OBP. Advisory committee: Neurology. Type: Traditional
Product code: OLV. Advisory committee: Neurology. Type: Special
Product code: JAK. Advisory committee: Radiology. Type: Traditional
Product code: JAK. Advisory committee: Radiology. Type: Traditional
Product code: MBI. Advisory committee: Orthopedic. Type: Special
Product code: EOB. Advisory committee: Ear, Nose, Throat. Type: Traditional
Product code: LNH. Advisory committee: Radiology. Type: Traditional
Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional
Product code: HSB. Advisory committee: Orthopedic. Type: Traditional
Product code: CBI. Advisory committee: Anesthesiology. Type: Traditional
Product code: DQX. Advisory committee: Cardiovascular. Type: Special
Product code: EHD. Advisory committee: Dental. Type: Traditional